Hospital Do Coracao
Clinical trials sponsored by Hospital Do Coracao, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Fewer radiation sessions could ease brain tumor treatment burden Results expected Oct 2026 (estimated)
- Global south ICUs under the microscope: new study tracks ventilator weaning practices Results expected Mar 2027 (estimated)
- New trial tests best timing for sepsis drug to save lives and kidneys Results expected Aug 2027 (estimated)
-
New trial tests best timing for sepsis drug to save lives and kidneys
Disease control Recruiting nowThis study tests whether giving vasopressin early, along with norepinephrine, is better than waiting to use it as a rescue treatment for people with septic shock. About 2,800 critically ill adults will be randomly assigned to one of two strategies. The main goal is to see which a…
Phase 3 • Sponsor: Hospital do Coracao • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could a single daily pill slash heart disease risks?
Disease control Recruiting nowThe EPOCA trial is testing whether a daily 'polypill' (combining blood pressure, cholesterol, and blood-thinning medications) plus the anti-inflammatory drug colchicine can reduce major heart and limb events in people with established heart disease. Over 7,700 participants aged 4…
Phase 3 • Sponsor: Hospital do Coracao • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Brazil launches massive heart gene hunt to unlock hereditary mysteries
Knowledge-focused Recruiting nowThis study is building a registry of 1,211 people in Brazil who have inherited heart conditions like cardiomyopathy, arrhythmias, and Marfan syndrome. Researchers will collect DNA samples and medical information to discover which genes are most commonly affected and how often the…
Sponsor: Hospital do Coracao • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC